Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Yacoubian TA"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Qiao Liyan, Hamamichi Shusei, Caldwell Kim A, Caldwell Guy A, Yacoubian Talene A, Wilson Scott, Xie Zuo-Lei, Speake Lisa D, Parks Rachael, Crabtree Donna, Liang Qiuli, Crimmins Stephen, Schneider Lonnie, Uchiyama Yasuo, Iwatsubo Takeshi, Zhou Yi, Peng Lisheng, Lu YouMing, Standaert David G, Walls Ken C, Shacka John J, Roth Kevin A, Zhang Jianhua
Publikováno v:
Molecular Brain, Vol 1, Iss 1, p 17 (2008)
Abstract α-synuclein (α-syn) is a main component of Lewy bodies (LB) that occur in many neurodegenerative diseases, including Parkinson's disease (PD), dementia with LB (DLB) and multi-system atrophy. α-syn mutations or amplifications are responsi
Externí odkaz:
https://doaj.org/article/e537a0cb3a7346ffbd10eea7ba929678
Autor:
Pattanayak R; Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, Heersink School of Medicine, University of Alabama at Birmingham, 1719 Sixth Avenue South, Civitan International Research Building 510, Birmingham, AL 35294, United States., Ekkatine R; Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, Heersink School of Medicine, University of Alabama at Birmingham, 1719 Sixth Avenue South, Civitan International Research Building 510, Birmingham, AL 35294, United States., Petit CM; Department of Biochemistry and Molecular Genetics, Heersink School of Medicine, University of Alabama at Birmingham, 720 20th Street South, Kaul 452, Birmingham, AL 35294, United States., Yacoubian TA; Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, Heersink School of Medicine, University of Alabama at Birmingham, 1719 Sixth Avenue South, Civitan International Research Building 510, Birmingham, AL 35294, United States.
Publikováno v:
Human molecular genetics [Hum Mol Genet] 2024 Sep 26. Date of Electronic Publication: 2024 Sep 26.
Autor:
Selvadurai LP; Department of Neurology, Ataxia Center, Cognitive Behavioral Neurology Unit, Laboratory for Neuroanatomy and Cerebellar Neurobiology, Massachusetts General Hospital and Harvard Medical School, 100 Cambridge Street, Suite 2000, Boston, MA, 02114, USA., Perlman SL; Department of Neurology, University of California, Los Angeles, Los Angeles, CA, USA., Ashizawa T; Department of Neurology, Houston Methodist Research Institute, Houston, TX, USA., Wilmot GR; Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA., Onyike CU; Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA., Rosenthal LS; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA., Shakkottai VG; Department of Neurology, University of Michigan, Ann Arbor, MI, USA.; Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Paulson HL; Department of Neurology, University of Michigan, Ann Arbor, MI, USA., Subramony SH; Department of Neurology, McKnight Brain Institute, University of Florida College of Medicine, Gainesville, FL, USA., Bushara KO; Department of Neurology, University of Minnesota, Minneapolis, MN, USA., Kuo SH; Department of Neurology, Columbia University, New York, NY, USA., Dietiker C; Department of Neurology, University of California, San Francisco, CA, USA., Geschwind MD; Department of Neurology, University of California, San Francisco, CA, USA., Nelson AB; Department of Neurology, University of California, San Francisco, CA, USA., Gomez CM; Department of Neurology, University of Chicago, Chicago, IL, USA., Opal P; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Zesiewicz TA; Department of Neurology, University of South Florida Ataxia Research Center, Tampa, FL, USA., Hawkins T; Department of Neurology, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA., Yacoubian TA; Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Nopoulos PC; Department of Psychiatry, University of Iowa Carver College of Medicine, Iowa City, IA, USA., Sha SJ; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA., Morrison PE; Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA., Figueroa KP; Department of Neurology, University of Utah, Salt Lake City, UT, USA., Pulst SM; Department of Neurology, University of Utah, Salt Lake City, UT, USA., Schmahmann JD; Department of Neurology, Ataxia Center, Cognitive Behavioral Neurology Unit, Laboratory for Neuroanatomy and Cerebellar Neurobiology, Massachusetts General Hospital and Harvard Medical School, 100 Cambridge Street, Suite 2000, Boston, MA, 02114, USA. jschmahmann@mgh.harvard.edu.
Publikováno v:
Cerebellum (London, England) [Cerebellum] 2024 Aug; Vol. 23 (4), pp. 1411-1425. Date of Electronic Publication: 2024 Jan 02.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Jun 24. Date of Electronic Publication: 2024 Jun 24.
Autor:
Yuan Y; Duke Center for Neurodegeneration and Neurotheraputics, Duke University, Durham, NC, USA.; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Li H; Duke Center for Neurodegeneration and Neurotheraputics, Duke University, Durham, NC, USA.; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Sreeram K; Duke Center for Neurodegeneration and Neurotheraputics, Duke University, Durham, NC, USA.; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Malankhanova T; Duke Center for Neurodegeneration and Neurotheraputics, Duke University, Durham, NC, USA.; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Boddu R; Duke Center for Neurodegeneration and Neurotheraputics, Duke University, Durham, NC, USA.; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Strader S; Duke Center for Neurodegeneration and Neurotheraputics, Duke University, Durham, NC, USA.; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Chang A; Duke Center for Neurodegeneration and Neurotheraputics, Duke University, Durham, NC, USA.; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Bryant N; Duke Center for Neurodegeneration and Neurotheraputics, Duke University, Durham, NC, USA.; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Yacoubian TA; Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA., Standaert DG; Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, USA., Erb M; Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, USA., Moore DJ; Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, USA., Sanders LH; Duke Center for Neurodegeneration and Neurotheraputics, Duke University, Durham, NC, USA.; Department of Neurology, Duke University, Durham, NC, USA.; Department of Pathology, Duke University, Durham, NC, USA., Lutz MW; Department of Neurology, Duke University, Durham, NC, USA.; Department of Pathology, Duke University, Durham, NC, USA., Velmeshev D; Department of Neurobiology, Duke University, Durham, NC, USA., West AB; Duke Center for Neurodegeneration and Neurotheraputics, Duke University, Durham, NC, USA. Andrew.West@Duke.edu.; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA. Andrew.West@Duke.edu.; Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA. Andrew.West@Duke.edu.; Department of Neurology, Duke University, Durham, NC, USA. Andrew.West@Duke.edu.; Department of Neurobiology, Duke University, Durham, NC, USA. Andrew.West@Duke.edu.
Publikováno v:
Molecular neurodegeneration [Mol Neurodegener] 2024 Jun 11; Vol. 19 (1), pp. 47. Date of Electronic Publication: 2024 Jun 11.
Autor:
Selvadurai LP; Ataxia Center, Cognitive Behavioral Neurology Unit, Laboratory for Neuroanatomy and Cerebellar Neurobiology, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Perlman SL; Department of Neurology, University of California, Los Angeles, Los Angeles, CA, USA., Wilmot GR; Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA., Subramony SH; Department of Neurology, University of Florida College of Medicine, McKnight Brain Institute, Gainesville, FL, USA., Gomez CM; Department of Neurology, University of Chicago, Chicago, IL, USA., Ashizawa T; Department of Neurology, Houston Methodist Research Institute, Houston, TX, USA., Paulson HL; Department of Neurology, University of Michigan, Ann Arbor, MI, USA., Onyike CU; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Rosenthal LS; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Sair HI; Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Kuo SH; Department of Neurology, Columbia University, New York, NY, USA., Ratai EM; Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Zesiewicz TA; Department of Neurology, Ataxia Research Center, University of South Florida, Tampa, FL, USA., Bushara KO; Department of Neurology, University of Minnesota, Minneapolis, MN, USA., Öz G; Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, MN, USA., Dietiker C; Department of Neurology, University of California, San Francisco, CA, USA., Geschwind MD; Department of Neurology, University of California, San Francisco, CA, USA., Nelson AB; Department of Neurology, University of California, San Francisco, CA, USA., Opal P; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Yacoubian TA; Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA., Nopoulos PC; Department of Psychiatry, University of Iowa Carver College of Medicine, Iowa City, IA, USA., Shakkottai VG; Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Figueroa KP; Department of Neurology, University of Utah, Salt Lake City, UT, USA., Pulst SM; Department of Neurology, University of Utah, Salt Lake City, UT, USA., Morrison PE; Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA., Schmahmann JD; Ataxia Center, Cognitive Behavioral Neurology Unit, Laboratory for Neuroanatomy and Cerebellar Neurobiology, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. jschmahmann@mgh.harvard.edu.
Publikováno v:
Cerebellum (London, England) [Cerebellum] 2023 Oct; Vol. 22 (5), pp. 790-809. Date of Electronic Publication: 2022 Aug 12.
Autor:
Pattanayak R; Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, Heersink School of Medicine, University of Alabama at Birmingham, 1719 Sixth Avenue South, Civitan International Research Building 510A, Birmingham, AL 35294, USA., Petit CM; Department of Biochemistry and Molecular Genetics, Heersink School of Medicine, University of Alabama at Birmingham, 720 20 Street South, Kaul 452, Birmingham, AL 35294, USA., Yacoubian TA; Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, Heersink School of Medicine, University of Alabama at Birmingham, 1719 Sixth Avenue South, Civitan International Research Building 510A, Birmingham, AL 35294, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 May 30. Date of Electronic Publication: 2023 May 30.
Autor:
Yacoubian TA; Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Fang YD; Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Gerstenecker A; Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Amara A; Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Stover N; Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Ruffrage L; Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Collette C; Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Kennedy R; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Zhang Y; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Hong H; Department of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Qin H; Department of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA., McConathy J; Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Benveniste EN; Department of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Standaert DG; Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2023 May; Vol. 38 (5), pp. 743-754. Date of Electronic Publication: 2023 Feb 28.
Autor:
Gannon M; Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294., Wang B; Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294., Stringfellow SA; Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294.; University of South Alabama College of Medicine, Mobile, AL 36688., Quintin S; Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294.; Medical Scientist Training Program, University of Florida, Gainesville, FL 32611., Mendoza I; Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294., Srikantha T; Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294., Roberts AC; Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294., Saito T; RIKEN Center for Brain Science, Saitama 351-0198, Japan.; Department of Neurocognitive Science, Institute of Brain Science, Nagoya City University Graduates School of Medical Sciences, Nagaya 467-8601, Japan., Saido TC; RIKEN Center for Brain Science, Saitama 351-0198, Japan., Roberson ED; Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294., Yacoubian TA; Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294 tyacoubian@uabmc.edu.
Publikováno v:
ENeuro [eNeuro] 2022 Jun 24; Vol. 9 (3). Date of Electronic Publication: 2022 Jun 24 (Print Publication: 2022).